Oncogenic osteomalacia associated with prostate cancer

Journal of Urology

Volumn 158, Issue 3, 1997, Pages 887-

  Reese, D M ^a   Rosen, P J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypophosphatemia; Osteomalacia; Prostate

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; PHOSPHORUS; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CACHEXIA; CANCER PATIENT; CASE REPORT; CLINICAL FEATURE; DIET SUPPLEMENTATION; HUMAN; HYPOPHOSPHATEMIA; MALE; OSTEOMALACIA; PRIORITY JOURNAL; PROSTATE CANCER; SYNDROME DELINEATION; VITAMIN INTAKE;

EID: 0030795461     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64351-9     Document Type: Article

References (5)

1. Weidner N. Bar R.S. Weiss D. Strottmann M.P. Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer 55 1985 1691
2. Ryan E.A. Reiss E. Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Amer. J. Med. 77 1984 501
3. Cai Q. Hodgson S.F. Kao P.C. Lennon V.A. Klee G.G. Zinsmeister A.R. Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. New Engl. J. Med. 330 1994 1645
4. Wilkins G.E. Granleese S. Hegele R.G. Holden J. Anderson D.W. Bondy G.P. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J. Clin. Endocr. Metab. 80 1995 1628
5. Miyauchi A. Fukase M. Tsutsumi M. Fujita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D1-hydroxylase activity. J. Clin. Endocr. Metab. 67 1988 46